1. Home
  2. WTO vs KZIA Comparison

WTO vs KZIA Comparison

Compare WTO & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTO
  • KZIA
  • Stock Information
  • Founded
  • WTO 2008
  • KZIA 1994
  • Country
  • WTO China
  • KZIA Australia
  • Employees
  • WTO N/A
  • KZIA N/A
  • Industry
  • WTO Consumer Electronics/Appliances
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WTO Technology
  • KZIA Health Care
  • Exchange
  • WTO Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • WTO 8.0M
  • KZIA 6.0M
  • IPO Year
  • WTO 2021
  • KZIA 1999
  • Fundamental
  • Price
  • WTO $0.28
  • KZIA $0.90
  • Analyst Decision
  • WTO
  • KZIA Strong Buy
  • Analyst Count
  • WTO 0
  • KZIA 2
  • Target Price
  • WTO N/A
  • KZIA $11.50
  • AVG Volume (30 Days)
  • WTO 482.7K
  • KZIA 5.5M
  • Earning Date
  • WTO 02-24-2025
  • KZIA 03-26-2025
  • Dividend Yield
  • WTO N/A
  • KZIA N/A
  • EPS Growth
  • WTO N/A
  • KZIA N/A
  • EPS
  • WTO N/A
  • KZIA N/A
  • Revenue
  • WTO $32,309,502.00
  • KZIA $1,655,324.00
  • Revenue This Year
  • WTO N/A
  • KZIA N/A
  • Revenue Next Year
  • WTO N/A
  • KZIA N/A
  • P/E Ratio
  • WTO N/A
  • KZIA N/A
  • Revenue Growth
  • WTO 47.36
  • KZIA 248000.00
  • 52 Week Low
  • WTO $0.25
  • KZIA $0.87
  • 52 Week High
  • WTO $62.25
  • KZIA $15.80
  • Technical
  • Relative Strength Index (RSI)
  • WTO 43.18
  • KZIA 29.40
  • Support Level
  • WTO $0.27
  • KZIA $0.90
  • Resistance Level
  • WTO $0.30
  • KZIA $1.60
  • Average True Range (ATR)
  • WTO 0.02
  • KZIA 0.23
  • MACD
  • WTO 0.00
  • KZIA 0.01
  • Stochastic Oscillator
  • WTO 42.86
  • KZIA 1.53

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: